Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.
Worldwide, the prevalence of noncommunicable chronic diseases is increasing. The use of vaccines to induce autoantibodies that neutralize disease-related proteins offers a means to effectively and affordably treat such diseases. Twenty vaccines designed to induce therapeutic autoantibodies were clin...
Main Authors: | Jennings, G, Bachmann, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
by: Link, A, et al.
Published: (2010) -
Therapeutic vaccines for chronic diseases: successes and technical challenges.
by: Bachmann, M, et al.
Published: (2011) -
A VLP-based vaccine against interleukin-1α protects mice from atherosclerosis.
by: Tissot, A, et al.
Published: (2013) -
RNA Phage VLP-Based Vaccine Platforms
by: David S. Peabody, et al.
Published: (2021-08-01) -
A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
by: Spohn, G, et al.
Published: (2010)